Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05390567

Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women

Project CONTINUITY (Connecting You to Care in the Community) was developed to increase adherence to cervical cancer screening regimens from initial screening to needed follow-up care by (1) providing personalized approaches to improve adherence through the combined use of patient choice for the initial screening method (Pap/HPV co-testing vs. HPV self-test collection), community clinical navigators and community health workers (CHWs), customized messages and support for patient portal access for test results and (2) implementing strategies to address social determinants of health (SDoH) that may influence an individual's ability to adhere to the screening regimen, with an initial focus on removing transportation barriers through the use of a mobile outreach clinics (MOC).

Recruiting

Interested in participating?

Request Info

Key information

Age range

25 year–65 year

Sex eligibility

Female

Study type

Observational

Primary location

University of Florida

Gainesville, Florida, 32610, United States

Location status: Recruiting

Location contact

Jennifer Woodard, RN, MPH

CONTACT

[email protected]

352-259-5574

About this study

The purpose of this pilot project is to gather information about the extent to which women residing in high SEV neighborhoods who choose HPV self-sampling relative to in-clinic Pap/HPV testing adhere to the cancer screening continuum steps, for which they are eligible. The women will self-select into HPV self-sampling versus in-clinic Pap/HPV testing combined with follow-up telephone calls and text messages from community clinical navigators and CHWs.

The research components of this study involve: 1) offering women the opportunity to complete the HPV self-test in a non-clinical setting to be returned via a mailer or handed to the community clinical navigator or CHW and 2) asking women to respond to questions about their cancer history and knowledge of cervical cancer prevention and screening. All other components of this study are part of clinical care. All other planned activities align with clinically based recommendations and guidelines (e.g., follow-up for colposcopy for + Paps)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Using the American Cancer Society (ACS) screening recommendations, adults 25 to 65 will be eligible.
  • Assigned sex at birth is female
  • No previous history of cervical cancer
  • No previous history of a hysterectomy
  • Not currently pregnant (self-report)
  • Not currently menstruating*
  • Have not used any vaginal products (e.g., oil-based lubricants, antifungal, and douches) in prior 2 days*. Use of vaginal contraceptives, condoms and water-based lubricants are allowed.
  • Have not given birth in the prior 12 weeks*
  • Self-report they have not undergone cancer screening in the past 4 years or more OR report being past due according to provider recommended screening schedule.
  • Self-report of using the MOC in the past, no current usual source of care OR usual source of care is a non-UFH provider and/or cervical cancer screening is not accessible through that provider
  • Reside in census tracts where the Mobile Outreach Clinic travels.
  • Have a mobile phone or access to a mobile phone that can be used to receive messages or a valid email address.

Exclusion criteria

  • For patients who are excluded for criterion 6, 7, and 8, the outreach team (community clinical navigator and CHW) will ask the participant if they can be re-contacted for potential future study eligibility assessment. If the participant agrees, the navigator or CHW will collect contact information to re-contact the participant at a later (pre-determined) date up to 20 weeks later for eligibility screening.

Treatment and study plan

Participant Choice of HPV Self-Test

Behavioral

Opportunity for participants to complete the HPV self-test in a non-clinical setting to be returned via a mailer or courier servie.

Survey: Participant cancer history and cervical cancer prevention/screening knowledge

Behavioral

Asking women to respond to questions about their cancer history and knowledge of cervical cancer prevention and screening.

Participant Choice of Standard of Care in-clinic Pap-test

Behavioral

Participant choice of cervical cancer screening method with either a SOC in-clinic pap test or HPV self-test

Primary outcomes

  1. Adherence to steps in the cervical cancer screening continuum

    Time frame: 6 months

    For the HPV self-testing group,

    • HPV test returned (Yes or No)
    • Results obtained (Yes or No)
    • Follow-up Pap test completed among those who tested positive for HPV (Yes or No)
    • Follow-up colposcopy completed among those who had positive Pap test (Yes or No) For the in-clinic testing group,
    • In-clinic Pap test completed (Yes or No) 2. Results Obtained (Yes or No) 3. Follow-up colposcopy completed among those who had positive Pap test (Yes or No)

Study contacts

Contact information is provided by the study sponsor or research team.

Jamie Barrow, MHA, CCRP

CONTACT

[email protected]

352-3253703

Jennifer N Woodard, MPH, CCRP

CONTACT

[email protected]

352-294-5974

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
May 25, 2022
Registry last updated
Jul 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.